Market Overview

Global Insulin Pumps Industry 2018-2024: Rapid Growth in Emerging Countries - ResearchAndMarkets.com

Share:

The "Global
Insulin Pumps Industry (China-specific Market Assessment) - Drivers,
Restraints, Opportunities, Trends, and Forecasts: 2018-2024"

report has been added to ResearchAndMarkets.com's
offering.

The global insulin pumps market is estimated to witness a CAGR of 9.7%
during the forecast period 2018-2024. Increased prevalence of diabetes,
growing popularity of advanced insulin pumps, and the introduction of
new technologies are driving the market growth.

North America is set to be the leading region for the insulin pumps
market growth followed by Europe. Asia Pacific and ROW are set to be the
emerging regions. The emerging markets have a high potential to grow
owing to an increase in patient population and focus toward healthcare
infrastructure.

The insulin pumps market has the lowest penetration in emerging regions,
and most of the vendors are targeting India, Thailand, Indonesia, and
Vietnam. These countries are the major revenue contributors in the APAC
region. A higher incidence of obesity will fuel the market expansion,
which will result in the high prevalence of diabetes.

Tethered insulin pump is dominating with more than 70% of the market
share. Increasing aging population, rise in prevalence of diabetes, need
for early prevention of diseases, and growing awareness about a healthy
lifestyle are expected to drive the market growth.

The insulin pumps market is highly fragmented and has immense growth
opportunities for vendors, especially in developing regions. The market
has the presence of many global, regional, and local players with strong
competition among each other.

Market Dynamics

Drivers

  • Huge Surge in Aging Population
  • Increase in Awareness
  • Increasing Number of Diabetic Patients
  • Rising Incidences of Government Initiatives

Opportunities

  • Technological Advances in Insulin Pump
  • Insulin Pumps Replacing Traditional Methods
  • Increasing Partnership and Collaboration Activities
  • Focus on Early Diabetes Management
  • Rapid Growth in Emerging Countries

Restraints

  • High Price of Latest Insulin Pumps
  • Unfavorable Reimbursement Plans
  • Availability of Substitutes
  • Competition Among Major Vendors

Companies Featured

  • F. Hoffmann-La Roche (Roche) Ltd.
  • Insulet Corp.
  • Medtronic plc
  • MicroPort Scientific Corp.
  • Tandem Diabetes Care
  • Eli Lilly and Company
  • Animas Corp.
  • Sooil Development Co. Ltd.
  • Ypsomed Holding AG
  • Valeritas Inc.
  • GlySens ICGM

For more information about this report visit https://www.researchandmarkets.com/research/lqbtzb/global_insulin?w=4

View Comments and Join the Discussion!